Inventor · disambiguated record
Holly Koblish
Also filed as: KOBLISH HOLLY · KOBLISH HOLLY K
5 granted patents·4 pending applications·60 citations·filing 1999–2024
76Inventor score
Top patents by PatentIndex Score
9 records- 0184US12214036B2Combination therapy comprising AXL/MER and PD-1/PD-L1 inhibitorsINCYTE CORP·Filed 2021·Granted Feb 4, 2025·1 cites·17 claims
- 0284US12065494B2Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agentINCYTE CORP·Filed 2022·Granted Aug 20, 2024·2 cites·13 claims
- 0383US10596161B2Low dose combination therapy for treatment of myeloproliferative neoplasmsINCYTE CORP·Filed 2018·Granted Mar 24, 2020·2 cites·28 claims
- 0482US6375944B1Methods and compositions for enhancing the immunostimulatory effect of interleukin-12WISTAR INST·Filed 1999·Granted Apr 23, 2002·55 cites·18 claims
- 0574US2025228936A1Combination therapy comprising axl/mer and pd-1/pd-l1 inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 0658US11278541B2Low dose combination therapy for treatment of myeloproliferative neoplasmsINCYTE CORP·Filed 2020·Granted Mar 22, 2022·0 cites·36 claims
- 0752US2002081277A1Methods and compositions for enhancing the immunostimulatory effect of interleukin-12Filed 2002·Application pending·0 cites
- 0848US2006189511A1Method for cytoprotection through mdm2 and hdm2 inhibitionKOBLISH HOLLY K·Filed 2003·Application pending·0 cites
- 0945US2005227932A1Combinational therapy involving a small molecule inhibitor of the MDM2: p53 interactionLU TIANBAO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Holly Koblish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →